Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)

Main Article Content

Diamant Thaci
Alice Gottlieb
Kristian Reich
Jerry Bagel
Daniel Burge
Luke Peterson
Janice Drew
Catherine Arendt
Jolanta Weglowska


psoriasis, certolizumab, randomized trial, multicenter


Abstract Not Available


Disclosure: Study supported by Dermira.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>